There are unique considerations to factor in treating COVID-19 in children and pregnant women. While COVID-19 disease among children have been less severe than in adults, very young children appear to be at the highest risk of severe disease. Join this webinar to learn how we can build tools and processes to help tailor therapies for COVID-19 and future outbreaks to meet the needs of special populations.
Dr. Jeff Barrett, former Head of Quantitative Sciences at the Bill & Melinda Gates Medical Research Institute (MRI)
Dr. Patrick Smith, SVP of Integrated Drug Development Strategy – Certara
Dr Karen Rowland Yeo, SVP, Client & Regulatory Strategy – Certara